Did you know that the UA is Water Resources Program is ranked #1 by the Shanghai Rankings of World Universities? UA inventors have developed a number of promising solutions that are ready for companies to adopt. Check them out.
Startup GenetiRate – founded on an invention out of the College of Agriculture & Life Sciences – is one of two companies honored with the Seafood Innovation Award at the North Atlantic Seafood Forum (NASF) 2019.
At its 32nd Annual IMPACT Awards, the Phoenix GPC awarded the honor to the startup founded on inventions developed at the College of Optical Sciences.
Throughout March, we recognize Women’s History Month and the accomplishments and contributions of women throughout society. At Tech Launch Arizona, we’re taking this opportunity to celebrate the amazing women on our team.
As rats have been nibbling at the edges of society, UA researchers were developing a non-reproductive rodent model for studying menopause. That work yielded a humane, non-lethal rodent infertility formulation, now being commercialized by startup SenesTech.
In the lab of Louise Hecker, PhD, researchers have invented the first highly selective Nox4 small molecule inhibitors for the treatment of fibrotic disorders. The UA has licensed the technology to startup Fibronox to bring the invention to the public.
Jeffrey Pyun, PhD, professor in the Department of Chemistry and Biochemistry, has been elected as a Senior Member of the National Academy of Inventors. Dr. Pyun is one of just 66 inventors around the nation who earned the honor.
Six teams went head-to-head during a shark tank-style competition hosted by the College of Medicine – Tucson. For their work to reduce asthma attacks, Monica Kraft, MD, and Julie Ledford, PhD, were named the competition winners.
Last year, the drivers behind startup SinfoniaRx announced the launch of UAVenture Capital to support commercialization at the UA. Now, they are announcing a second fund targeting $100 million to further the advance of UA innovations.
Through TLA, the University of Arizona is partnering with Kerafast to license reagents that offer the opportunity for the development of a rapid, highly sensitive diagnostic test for Cryptosporidiosis, the leading cause of waterborne diseases among people in the U.S.